|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acute Respiratory Failure | |||||
| Lung Diseases | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Respiratory Insufficiency | |||||
| 3 | More general conditions related to this trial | ||||
| Respiration Disorders | |||||
| Respiratory Tract Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| extracorporeal membrane oxygenation | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||